Justyna Kocik-Krol (Justyna Kocik)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Molecular Dynamics Simulations

Human Serum Albumin

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ewa Surmiak, Julia Ząber, Jacek Plewka, Grzegorz Wojtanowicz, Justyna Kocik-Krol, Oskar Kruc, Damian Muszak, Ismael Rodriguez, Bogdan M Musielak, Monica Viviano, Sabrina Castellano, Łukasz Skalniak, Katarzyna Magiera-Mularz, Tad A Holak, Justyna Kalinowska-Tłuścik
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m -Terphenyl Derivatives. ACS medicinal chemistry letters 15 (1) (2023)
Ewa Surmiak, Julia Ząber, Jacek Plewka, Grzegorz Wojtanowicz, Justyna Kocik-Krol, Oskar Kruc, Damian Muszak, Ismael Rodriguez, Bogdan M Musielak, Monica Viviano, Sabrina Castellano, Łukasz Skalniak, Katarzyna Magiera-Mularz, Tad A Holak, Justyna Kalinowska-Tłuścik
Solubilizer Tag Effect on PD-L1/Inhibitor Binding Properties for m -Terphenyl Derivatives. ACS medicinal chemistry letters 15 (1) (2023)
Shabnam Shaabani, Louis Gadina, Ewa Surmiak, Zefeng Wang, Bidong Zhang, Roberto Butera, Tryfon Zarganes-Tzitzikas, Ismael Rodriguez, Justyna Kocik-Krol, Katarzyna Magiera-Mularz, Łukasz Skalniak, Alexander S S Dömling, Tad A Holak
Biphenyl Ether Analogs Containing Pomalidomide as Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction. Molecules (Basel, Switzerland) 27 (11) (2022)
Damian Muszak, Ewa Surmiak, Jacek Plewka, Katarzyna Magiera-Mularz, Justyna Kocik-Krol, Bogdan M Musielak, Dominik Sala, Radoslaw Kitel, Malgorzata Stec, Kazimierz Weglarczyk, Maciej Siedlar, Alexander S S Dömling, Łukasz Skalniak, Tad A Holak
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein Interaction. Journal of medicinal chemistry 64 (15) (2021)
Ewa Surmiak, Katarzyna Magiera-Mularz, Bogdan M Musielak, Damian Muszak, Justyna Kocik-Krol, Radoslaw Kitel, Jacek Plewka, Tad A Holak, Łukasz Skalniak
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action. International journal of molecular sciences 22 (21) (2021)
Magdalena Konieczny, Bogdan M Musielak, Justyna Kocik-Krol, Łukasz Skalniak, Dominik Sala, Miroslawa Czub, Katarzyna Magiera-Mularz, Ismael Rodriguez, Maja Myrcha, Malgorzata Stec, Maciej Siedlar, Tad A Holak, Jacek Plewka
Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune Checkpoint. Journal of medicinal chemistry 63 (19) (2020)
Justyna Kocik-Krol, Monika Machula, Aneta Wisniewska, Ewa Surmiak, Tad A Holak, Łukasz Skalniak
Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists. Cancers 11 (7) (2019)
Bogdan M Musielak, Justyna Kocik-Krol, Łukasz Skalniak, Katarzyna Magiera-Mularz, Dominik Sala, Miroslawa Czub, Malgorzata Stec, Maciej Siedlar, Tad A Holak, Jacek Plewka
CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not? Molecules (Basel, Switzerland) 24 (15) (2019)
Łukasz Skalniak, Justyna Kocik-Krol, Justyna Polak, Anna Skalniak, Monika Rak, Agnieszka Wolnicka-Glubisz, Tad A Holak
Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells. Cancers 10 (11) (2018)